-
Posted by
Two Blokes Jun 13 -
Filed in
Stock
-
7 views
Medicus Pharma (NASDAQ:MDCX) earlier this week announced the submission of a veterinary clinical development program to the FDA targeting squamous cell carcinoma in horses. The move follows the company's receipt of an orphan drug designation for the condition from the veterinary division of the agency.
